Clinical Trials Browser

Recurrence × Paclitaxel × Breast × Clear all

NCT03315364 2026-04-01

OPTIMAL

Phase 2/3 Active not recruiting

Breast Neoplasms, Recurrence

NCT03326102 2024-02-16

OPERA

Phase 2 Completed

Breast Neoplasms, Recurrence

NCT00448305 2012-01-05

EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis, Recurrence